Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) kicked off on Monday, down -5.22% from the previous trading day, before settling in for the closing price of $1.34. Over the past 52 weeks, IRWD has traded in a range of $1.25-$8.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -3.28%. While this was happening, its average annual earnings per share was recorded 325.00%. With a float of $156.67 million, this company’s outstanding shares have now reached $160.21 million.
Let’s determine the extent of company efficiency that accounts for 253 employees. In terms of profitability, gross margin is 99.71%, operating margin of 27.7%, and the pretax margin is 18.86%.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Ironwood Pharmaceuticals Inc is 3.17%, while institutional ownership is 101.83%. The most recent insider transaction that took place on Feb 10 ’25, was worth 244,753. In this transaction Chief Executive Officer of this company sold 139,064 shares at a rate of $1.76, taking the stock ownership to the 1,160,634 shares. Before that another transaction happened on Feb 10 ’25, when Company’s Principal Accounting Officer sold 12,048 for $1.76, making the entire transaction worth $21,204. This insider now owns 279,655 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 325.00% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Take a look at Ironwood Pharmaceuticals Inc’s (IRWD) current performance indicators. Last quarter, stock had a quick ratio of 4.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.58. Likewise, its price to free cash flow for the trailing twelve months is 1.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.01, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.22 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Looking closely at Ironwood Pharmaceuticals Inc (NASDAQ: IRWD), its last 5-days average volume was 1.85 million, which is a drop from its year-to-date volume of 3.18 million. As of the previous 9 days, the stock’s Stochastic %D was 25.14%. Additionally, its Average True Range was 0.13.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 2.03%, which indicates a significant decrease from 22.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.89% in the past 14 days, which was lower than the 105.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7943, while its 200-day Moving Average is $3.9825. However, in the short run, Ironwood Pharmaceuticals Inc’s stock first resistance to watch stands at $1.3233. Second resistance stands at $1.3767. The third major resistance level sits at $1.4433. If the price goes on to break the first support level at $1.2033, it is likely to go to the next support level at $1.1367. Should the price break the second support level, the third support level stands at $1.0833.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
The company with the Market Capitalisation of 205.50 million has total of 161,809K Shares Outstanding. Its annual sales at the moment are 351,410 K in contrast with the sum of 1,810 K annual income. Company’s last quarter sales were recorded 90,550 K and last quarter income was 3,190 K.
